Stratton John G
SEC Form 4 insider trading activity
Stratton John G has filed 10 SEC Form 4 filings (11 transaction rows) across 3 companies, including GD, ABT, FYBR, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Stratton John G is listed as Director at ABBOTT LABORATORIES. Inside the rolling window, Stratton John G reported 1 open-market purchase totaling $174K in ABT and no open-market sales.
Companies traded
Other insiders at GD
Insider Buying
$174K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stratton John G made?
Stratton John G has filed 10 SEC Form 4 filings (11 transaction rows) across 3 companies, including GD, ABT, FYBR since 2025.
Which companies does Stratton John G trade?
Stratton John G has filed SEC Form 4 disclosures for 3 companies, including GD, ABT, FYBR.
When was Stratton John G's most recent SEC Form 4 filing?
Stratton John G's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Stratton John G's total buy and sell value in the current window?
Inside the rolling retention window, Stratton John G bought $174K and sold $0 based on SEC Form 4 filings.
What was Stratton John G's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,000 ABT shares on 2026-05-07, worth $174K, per SEC Form 4 filings.